MEI Return On Tangible Assets from 2010 to 2025
| MEIP Stock | USD 2.43 0.03 1.22% |
Return On Tangible Assets | First Reported 2010-12-31 | Previous Quarter 0.39 | Current Value 0.41 | Quarterly Volatility 0.41810113 |
Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.
MEI | Return On Tangible Assets |
Latest MEI Pharma's Return On Tangible Assets Growth Pattern
Below is the plot of the Return On Tangible Assets of MEI Pharma over the last few years. It is a profitability metric that measures a company's ability to generate earnings from its tangible assets. MEI Pharma's Return On Tangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.
| Return On Tangible Assets | 10 Years Trend |
|
Return On Tangible Assets |
| Timeline |
MEI Return On Tangible Assets Regression Statistics
| Arithmetic Mean | (0.25) | |
| Geometric Mean | 0.34 | |
| Coefficient Of Variation | (169.04) | |
| Mean Deviation | 0.29 | |
| Median | (0.26) | |
| Standard Deviation | 0.42 | |
| Sample Variance | 0.17 | |
| Range | 1.6101 | |
| R-Value | 0.81 | |
| Mean Square Error | 0.06 | |
| R-Squared | 0.66 | |
| Significance | 0.0001 | |
| Slope | 0.07 | |
| Total Sum of Squares | 2.62 |
MEI Return On Tangible Assets History
About MEI Pharma Financial Statements
MEI Pharma shareholders use historical fundamental indicators, such as Return On Tangible Assets, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.39 | 0.41 |
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.